Pfizer Head Says 15 Drugs Headed To Japan Market Over Next Five Years
This article was originally published in PharmAsia News
Executive Summary
Pfizer Inc. CEO Ian Read revealed his company plans to introduce 15 drugs in the Japanese market within the next five years to help make up for patent-expirations of some of the firm’s key drugs.